As summarized in Table 2, there were no significant correlations between the expression level of FLOT2 protein and patient age, N classification, estrogen receptor (ER) expression levels or progesterone receptor (PR) in patients with breast cancer. Here, FLOT2 is linked to breast carcinoma.